Hyderabad, India – Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced an ambitious…
Read More
Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026 in Boston, Forging Critical Alliances for Future Drug Discovery
Boston, MA – Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently convened its highly…
Read More
Rubedo Life Sciences Pivots from Cosmetic Enhancement to Biological Rejuvenation with Senescent Cell Clearance for Age-Related Skin Conditions
Dr. Frederick Beddingfield III, a seasoned pharmaceutical executive known for his instrumental role in scaling Botox into a multi-billion-dollar franchise…
Read More
Sai Life Sciences Plans to Recruit 700+ Professionals in FY27 as Indian CRDMO Demand Accelerates
Sai Life Sciences, a leading Contract Research, Development, and Manufacturing Organization (CRDMO) based in Hyderabad, India, has announced an ambitious…
Read More
Merck KGaA Acquires JSR Life Sciences’ Chromatography Business to Bolster Biopharmaceutical Purification Capabilities
Germany-based Merck KGaA, a leading science and technology company, has officially completed its previously announced acquisition of the chromatography business…
Read More
The UK Must Supercharge Its Commercial Strategy to Boost Global Life Sciences Competitiveness
Off the northwestern coast of mainland Europe, an island nation with significant ambitions for its life sciences sector is navigating…
Read More
Rubedo Life Sciences Charts Ambitious Course to Reverse Skin Aging and Disease Through Targeted Senescent Cell Clearance
In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…
Read More
Sai Life Sciences plans to recruit 700+ professionals in FY27 as Indian CRDMO demand accelerates
Hyderabad-based Sai Life Sciences, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), has announced ambitious plans to hire more…
Read More
Gilead Sciences to Acquire Ouro Medicines for $2.2 Billion, Ushering in New Era of T-Cell Engagers in Autoimmune Diseases
Gilead Sciences is poised to make a significant entry into the burgeoning field of T-cell engagers (TCEs) with its $2.2…
Read More
Rubedo Life Sciences Pioneers Senolytic Approach to Reverse Skin Aging and Treat Inflammatory Dermatoses
In a significant shift within the pharmaceutical and longevity sectors, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick…
Read More
